A significant breakthrough in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of tumors, leading https://admiralbookmarks.com/story22043224/nanobodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-management